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Available online 4 July 2019Background: Cardiac rehabilitation (CR) is a clinically-effective but complex model of care. The purpose of this
studywas to characterize the nature of CRprograms around theworld, in relation to guideline recommendations,
and compare this by World Health Organization (WHO) region.
Methods: In this cross-sectional study, a piloted surveywas administered online to CR programs globally. Cardiac
associations and local champions facilitated program identification. Quality (benchmark of ≥75% of programs in a
given country meeting each of 20 indicators) was ranked. Results were compared by WHO region using gener-
alized linear mixed models.
Findings: 111/203 (54.7%) countries in the world offer CR; data were collected in 93 (83.8%; N = 1082 surveys,
32.1% program response rate). The most commonly-accepted indications were: myocardial infarction (n =
832, 97.4%), percutaneous coronary intervention (n = 820, 96.1%; 0.10), and coronary artery bypass surgery
(n = 817, 95.8%). Most programs were led by physicians (n = 680; 69.1%). The most common CR providers
(mean = 5.9 ± 2.8/program) were: nurses (n = 816, 88.1%; low in Africa, p b 0.001), dietitians (n = 739,
80.2%), and physiotherapists (n = 733, 79.3%). The most commonly-offered core components (mean = 8.7 ±
1.9 program) were: initial assessment (n= 939, 98.8%; most commonly for hypertension, tobacco, and physical
inactivity), risk factormanagement (n=928, 98.2%), patient education (n=895, 96.9%), and exercise (n= 898,
94.3%; lower inWestern Pacific, p b 0.01). All regionsmet ≥16/20 quality indicators, but quality was b75% for to-
bacco cessation and return-to-work counseling (lower in Americas, p = b0.05).
Interpretation: This first-ever survey of CR around the globe suggests CR quality is high. However, there is signif-
icant regional variation, which could impact patient outcomes.
© 2019 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Survey1. Introduction
Cardiac rehabilitation (CR) is an established model of care designed
to mitigate the great burden of cardiovascular diseases (CVD) globally
[1]. CR is a multi-component and hence complex intervention, so the
nature and quality of CR services may vary widely, impacting degree
of patient benefit. CR quality indicators or performance measures are
established by American [2], Australian [3], Canadian [4], and
European [5] CR societies. There are 20 CR components indicators that
are generally common employed, yet whether CR is delivered up to
these standards has been scantly characterized [6,7]. Indeed, the nature
of CR delivery has only been characterized in much less than half of
countries where it is believed to be offered, and it has not been charac-
terized in a comparable way [8].
For instance, CR referral is recommended in clinical practice guidelines
for CVD patients [9], those with heart failure (HF) [10,11], undergoing re-
vascularization [12,13], and with stable coronary artery disease [14],
based on robust meta-analytic evidence of approximately 20% reductions
in CVDmortality and re-hospitalization attributed to CR participation [1].
Benefits of CR in valve [15], transplant [16], and atrial fibrillation [17] pa-
tients are also established [18]. Despite this, CR guidelines vary in terms ofaccepted indications for CR [8,19], and funding policies differ from coun-
try to country in terms of indications covered [20]. This may lead to vari-
ability in care received by patients around the world.
Moreover, CR guidelines recommend a “multidisciplinary team”
[21–23], to ensure competent delivery of all the evidence-based ele-
ments of secondary prevention/core components (e.g., tobacco cessa-
tion interventions, dietary counseling, and stress management) [22],
and medical leadership for safety [24]. Yet, little is known about the
number and nature of healthcare professionals providing CR care
around the globe [8], and how this may impact delivery of all the core
components [3,20,24–26], including which CV risk factors are assessed
during the initial assessment component [5].
In this first-ever survey of CR programs worldwide, the nature of CR
services was assessed, specifically with regard to: (1) the type of pa-
tients served; (2) the number and types of healthcare professionals pro-
viding service, and (3) the core components delivered, in relation to
international guideline recommendations [26,27]. The nature of pro-
grams were compared by World Health Organization (WHO) region;
while it was hypothesized there would be statistically significant varia-
tion, given this the first time the nature of CR services has been
established globally, this study is exploratory.
Research in context
Evidence before this study
The burden of cardiovascular disease is increasing globally,
and cardiac rehabilitation (CR) is recognized as one of the most
beneficial and cost-effective strategies to manage it. However,
CR is a multi-component, and hence complex intervention, so
the nature and quality of CR services may vary widely, impacting
degree of patient benefit. Unfortunately, the nature of CR delivery
has only been characterized inmuch less than half of the countries
where it is offered around the world.
Added value of this study
For the first time, the nature of CR services in every country of
the globe where it is offered has been established, and compared.
This has been juxtaposed against international CR guidelines. Re-
sults showed that, where available, the quality of CR is high, but it
does vary significantly by region.
Implications of all the available evidence
While the association between the quality indicators and pa-
tient outcomes requires establishment, advocacy for greater de-
livery of smoking cessation, stress management/psychosocial as
well as counseling on return-to-work in the CR setting is needed,
potentially through greater inclusion of nurses on the CR team. A
global program accreditation mechanism could promote high-
quality, consistent CR around the world.
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2.1. Design & Procedure
This researchwas cross-sectional in design. The study was approved
by York University's Office of Research Ethics (Toronto, Canada; e2014-
078) and Mayo Clinic's Institutional Review Board (Rochester, United
States; 16-001110). Countries where CR services were available were
identified first through previous reviews [28,29], and communication
with CR and cardiology societies (see further detail elsewhere [30]).
For each country identified to offer CR, first, available society leadership
was contacted to solicit collaboration. If there was no society available
or response, “champions” were identified from the peer-reviewed, or
secondarily, gray literature/the web. Identified leaders were sent an
email requesting their assistance administering the survey to each pro-
gram in their country.
The lead clinician at each program identifiedwas emailed requesting
their completion of the survey. Informed consent was secured through
an online form. Data were collected through REDCap from June 2016–
July 2017. Contacts were sent two email reminders, at two week inter-
vals. The national contact was provided the response rate four weeks
following initial administration. Where it was b40%, they were invited
to suggest other approaches to increase response rate.2.2. Sample
The sample consisted of all CR programs identified in theworld, that
offered services to patients following an acute cardiac event or hospital-
ization (i.e., Phase II). This included residential programs [8]. The inclu-
sion criteria were CR programs that offered: (1) initial assessment,(2) structured exercise (supervised or not), and (3) at least one other
strategy to control CV risk factors. All programswere contacted in coun-
tries known to have ≤250 CR programs. Where more existed, a random
sub-sample of 250 was contacted. Random subsamples were generated
electronically using the simple random sample module SAS institute,
Cary, NC.
2.3. Measures
Development of the survey is described in detail elsewhere [30]. In
short, items were based on previous national/regional CR program sur-
veys [31–33]. Most items had forced-choice response options, and skip-
logicwas used to getmore detail where applicable. Thiswas pilot-tested
in the Arab world and Canada [30]. It was then revised based on re-
sponses and recent literature (see online supplement; please note
some questions have been slightly revised to improve clarity). The sur-
vey was translated to Portuguese, Spanish, and Mandarin (available
upon request). The translations were reviewed by a national champion
with the corresponding first language.
Overall, 20 structure and process quality indicators from CR societies
[2–5,34] were assessed through the survey. Delivery of the 11 following
core components was assessed: initial assessment, risk assessment/
stratification, exercise training, patient education, management of CV
risk factors, nutrition counseling, stress management, tobacco cessation
interventions, vocational counseling/return-to-work, communication
with primary care and end of program re-assessment (structure indica-
tors). Assessment of the following 8 risk factorswas also assessed: blood
pressure, lipids, physical inactivity, poor diet, adiposity (e.g., body mass
index, waist circumference, or body composition), tobacco use, glucose/
HbA1c, and depression (process indicators). CR wait times were also
assessed (benchmark b30 days; process indicator) [4].
2.4. Data Analysis
SPSS version 24 and SAS version 11 were used. All initiated surveys
were included. The number of responses for each question varied due
tomissing data (e.g., respondent did not answer a question due to inap-
plicability, use of skip logic); for descriptive analyses, percentages were
computed using the number of responses for the specific item as the
denominator.
Descriptive statistics (e.g., frequency with percentage or median
with quartiles, as appropriate) were applied for all closed-ended items
in the survey. All open-ended responses were coded; only those with
greater than 10% responses are reported herein.
Responses were then compared by WHO region (independent vari-
able). Clustering of program-level data within countries was taken into
consideration in these exploratory inferential tests. It was tested
whether the nature of programs (e.g., personnel, accepted indications;
i.e., dependent variables) differed by region using generalized linear
mixedmodels, with country as a random effect. Themodels were fitted
via the Poisson distribution log link function for continuous dependent
variables and via a binomial distribution with logit link function for cat-
egorical dependent variables, because the dependent variables were
often positively skewed. For each analysis, the distribution of the resid-
uals was reviewed to consider the model performance. While practical
importance could not be considered given the novelty of this study, p
b .05 was considered statistically significant where regional differences
were explored inferentially.
3. Results
As shown in Table 1, there were 111/203 (54.7%) countries in the
world with existent CR programs (Fig. 1 displays countries without),
of which data were collected in 93 (83.8%; Fig. 1 also displays countries
with CR where no programs responded). The number of responses per
49M. Supervia et al. / EClinicalMedicine 13 (2019) 46–56country, and response rates are shown by WHO region. More informa-
tion on CR availability and capacity is reported elsewhere [35].
Most (n = 775; 72.8%) programs were in an urban area. They were
most often located in a hospital (n = 851, 80.6%), which was most-
commonly a referral/tertiary center (n = 484; 46.1%). Most programs
were part of a cardiology (n= 392, 37.5%), or physical medicine and re-
habilitation (PMR) department (n= 251, 24.0%). The mean duration of
supervised CRwas 10.9± 9.4 (standard deviation;median= 8)weeks,
and frequency of sessions/week 2.5 ± 1.3 (median = 2.5). Alternative
models (i.e., not center-based; e.g., home-based) were offered by 285
(31.1%) programs, in 51 (45.9%) countries with CR (further detail else-
where) [36].
3.1. Accepted Indications for CR
The most common cardiac indications accepted (Fig. 1) included
those recommended in guidelines (all N80%; by region in Supplemental
Table 1 and country in Supplemental Table 2). Among programs in hos-
pitals that offered the procedures listed, ≥80% of programs accepted pa-
tients receiving these procedures. There were statistically significant
regional differences in acceptance of 3 non-cardiac indications (Supple-
mental Table 1).
3.2. CR Providers
The provider type with overall responsibility for the CR program was
most often a cardiologist (n=479, 48.4%), followed bynurses (n=168,
17.0%), and then physiatrists/PMR specialists (n= 123, 12.4%). Overall,
680 (69.1%) programs were headed by some type of physician, and this
did not vary byWHO region. Other physician types with overall respon-
sibility included: sportsmedicine (n= 18, 52.9%) and family physicians
(n = 6, 17.6%); other non-physician healthcare providers with overall
responsibility included: some form of administrator (i.e., manager, di-
rector; n = 6, 46.2%) and occupational therapists (n = 4, 30.8%).
Professionals on the teamweremost often nurses, dietitians, physio-
therapists, and cardiologists (Table 2; 4 varied by region; country-level
data for most common shown in Supplemental Table 3). Other types of
physicians on the CR team included: specialists in internal medicine (n
=32, 29.4%), and general/family physicians (n=24, 22.0%). Other non-
physician healthcare providers on the CR team included: occupational
therapists (n = 52, 35.4%) and other types of exercise professionals.
The median total number of staff per program (including those part-
time) was 5.5 (Q25-Q75 = 4.0–7.5; Table 2); this did not differ by re-
gion (association with program volumes reported elsewhere) [35].
Whether programs offer patients individual consultations with physi-
cians and nurses is shown by WHO region in Supplemental Table 4.
Physiotherapists and nursesweremost commonly present during ex-
ercise sessions,with no variation in total number present during exercise
(median=3.0, Q25-Q75=2.0–4.0; Table 2). Supplemental Table 5 dis-
plays cardiopulmonary resuscitation training of personnel supervising
exercise by WHO region and country. The median staff-to-patient
ratio during supervised exercise was 2.0 (Q25-Q75 = 1.0–3.0) to 8.0
(Q25-Q75 = 4.0–12.0), respectively (Table 2 displays that statistically
significantly more patients were served per staff member in Europe).
3.3. Core Components Delivered
Initial assessment (likely a reflection of inclusion criteria), risk factor
management and patient educationwere themost frequently-delivered
(Table 3; country-level data for key components shown in Supplemen-
tal Table 6), and on average, patients received 8.5 ± 10.8 (median= 6)
education sessions per program, with each session lasting 47.0 ± 29.7
(median = 45) minutes (further detail elsewhere [35]; also regarding
dose of exercise [37]). The median number of core components offered
by programs was 8.7 (Q25-Q75= 8.0–10.0). Supplemental Table 7 dis-
plays CR components and other elements delivered, by region byWHOregion. There were statistically significant regional differences in the el-
ements of exercise (lower in Western Pacific), tobacco cessation
counseling (lower in the Americas), return-to-work (lower in the
Americas), and women-only classes (higher in Eastern Mediterranean).
With regard to the core component of initial assessment, blood pres-
sure, tobacco use, physical inactivity, body mass index, harmful use of
alcohol, lipids, and diet assessment were all above 90% (Supplemental
Table 8;median= 12.0 assessed, Q25-Q75=11.0–14.0; no statistically
significant regional variation). Other risk factors assessed included:
family history/genetics (n= 22, 12.3%). Over 95% of programs assessed
some element of adiposity, and almost 90% assessed blood glucose in
some manner (Table 4).
Functional capacity tests such as the six-minute walk (n = 224,
65.1%) were used more often than a graded exercise stress test
(Table 3). Almost 95% of programs monitored exercise intensity. Over-
all, 441 (51.8%) programs monitored patients using telemetry during
supervised exercise, 391 (46.0%) used another method of monitoring
(e.g., perceived exertion, heart rate; with some reporting both), and
129 (15.2%) did not monitor during exercise (Supplemental Fig. 1).
Where programs were led by a physician (generalist or specialist),
patients were statistically significantly more likely to be prescribed
medications (89.8% vs 58.3%; p b 0.0001) than where programs were
not led by physicians. Programs with nurses or nurse-practitioners on
staff full or part-time were statistically significantly more likely to
offer the following components:management of cardiovascular risk fac-
tors (99.2% vs 92.2%; p b 0.001), nutrition counseling (95.1% vs 79.7%; p
b 0.001), depression screening (88.8% vs 73.4%; p b 0.001), psychologi-
cal counseling (83.0% vs 58.5%; p b 0.001), tobacco cessation interven-
tions (77.5% vs 51.8%; p b 0.001), counseling regarding return-to-work
(68.7% vs 48.9%; p b 0.001), stress management (83.8% vs 68.3%; p b
0.001), and women-only classes (13.3% vs 6.4%; p = 0.01).
3.4. Overall Quality
Structure and process quality were under the benchmark of 75% of
programs globally for only two indicators: tobacco cessation and
return-to-work counseling (Table 4). There was statistically significant
regional variation for these indicators (lower in Americas), aswell as ex-
ercise (lower in Western Pacific). Total quality was very high and did
not differ regionally (by country in Supplemental Table 9).
4. Discussion
In this first-ever global CR survey, the overall high quality of CR in
the half of countries where it is available was established. However, def-
icits were identified, as were statistically significant global variations.
Most programs appropriately accepted patients following acute coro-
nary syndrome and revascularization, but fewer accepted those with
heart failure, and stable coronary artery disease. Programs on average
consisted of six staff members, with most commonly a cardiologist as
medical director, with nurses, dietitians, physiotherapists, and adminis-
trative assistants on staff. Programs on average offered 9 of 11 recom-
mended core components, typically initial assessment, management of
risk factors, patient education, exercise, and nutrition counseling; to-
bacco cessation and vocational counseling/return-to-work (although
not applicable to all patients) were not as consistently offered.
4.1. Accepted Indications for CR
Given capacity constraints on CR programs to treat indicated pa-
tients, it was interesting to observe that well over half of programs ac-
cepted high-risk primary prevention patients, and almost half
accepted patients with peripheral arterial disease and diabetes as a pri-
mary indication. This may suggest providers see the value of preventive
care delivered in CR for other conditionswith common risk factors, par-
ticularly in Africa. How resources for treatment of these other
Table 1
Number of participating cardiac rehabilitation programs by country and WHO region, N = 111.
Region country Number of programs Number of responses Response rate
African
Algeria 1 1 100.0%
Benin 1 0 0.0%
Kenya 3 1 33.3%
Mauritius 1 1 100.0%
Nigeria 1 1 100.0%
South Africa 23 14 60.8%
Tanzania 1 0 0.0%
Uganda 1 0 0.0%
Subtotal (across 5/8 countries with CR; 62.5%) 32 18 56.3%
Americas
Argentina 23 3 13.0%
Aruba 1 0 0.0%
Barbados 1 1 100.0%
Bermuda 1 1 100.0%
Brazil 75 30 40.0%
Canada 170 57 33.5%
Chile 10 1 10.0%
Colombia 50 48 96.0%
Costa Rica 6 6 100.0%
Cuba 8 8 100.0%
Curacao 2 1 50.0%
Dominican Republic 2 1 50.0%
Ecuador 5 2 40.0%
El Salvador 2 0 0.0%
Grenada 1 0 0.0%
Guam 1 0 0.0%
Guatemala 2 2 100.0%
Honduras 2 1 50.0%
Jamaica 3 1 33.3%
Mexico 24 9 37.5%
Panama 1 1 100.0%
Paraguay 3 3 100.0%
Peru 10 7 70.0%
Puerto Rico 1 0 0.0%
Trinidad and Tobago 2 0 0.0%
United States of America 250a 65 26.0%
Uruguay 12 5 41.6%
Venezuela 9 8 88.9%
Subtotal (across 22/28 countries with CR; 78.6%) 677 261 38.6%
Eastern Mediterranean
Afghanistan 1 1 100.0%
Bahrain 1 1 100.0%
Egypt 2 2 100.0%
Iran 34 14 41.2%
Kuwait 1 0 0.0%
Lebanon 1 1 100.0%
Morocco 1 1 100.0%
Pakistan 4 2 50.0%
Qatar 1 1 100.0%
Saudi Arabia 1 0 0.0%
Tunisia 1 1 100.0%
United Arab Emirates 1 0 0.0%
Subtotal (across 9/12 countries with CR; 75.0%) 49 24 49.0%
Europe
Austriab 26 5 19.2%
Belarus 5 1 20.0%
Belgium 48 9 18.8%
Bosnia and Herzegovina 1 1 100.0%
Bulgaria 1 1 100.0%
Croatia 3 3 100.0%
Cyprus 1 0 0.0%
Czech Republic 15 6 40.0%
Denmark 35 8 22.9%
England 266 57 21.4%
Estonia 2 2 100.0%
Finland 25 11 44.0%
France 130 16 12.3%
Georgia 17 13 76.5%
Germany 120 34 28.3%
Greece 4 4 100.0%
Hungary 33 20 60.6%
Iceland 4 4 100.0%
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Table 1 (continued)
Region country Number of programs Number of responses Response rate
Ireland 37 7 18.9%
Israel 22 6 27.3%
Italy 221 70 31.7%
Kazakhstan 1 1 100.0%
Kyrgyzstan 1 0 0.0%
Latvia 2 1 50.0%
Lithuania 25 9 36.0%
Luxembourg 4 0 0.0%
Republic of Northern Macedonia 1 1 100.0%
Malta 1 1 100.0%
Montenegro 1 0 0.0%
Netherlands 90 29 32.2%
Northern Ireland 13 10 76.9%
Norway 35 0 0.0%
Poland 56 21 37.5%
Portugal 23 21 91.3%
Republic of Moldova 1 1 100.0%
Romania 3 2 66.7%
Russian Federation 3 3 100.0%
Scotlandb 69 24 34.8%
Serbia 2 2 100.0%
Slovak Republic 7 1 14.3%
Slovenia 2 2 100.0%
Spain 87 47 54.0%
Sweden 69 1 1.4%
Switzerland 51 4 7.8%
Turkey 10 9 90.0%
Wales 17 16 94.1%
Subtotal (across 41/46 countries with CR; 89.1%) 1590 484 30.4%
South-East Asia
Bangladesh 1 1 100.0%
India 23 18 78.3%
Indonesia 13 10 76.9%
Nepal 1 1 100.0%
Sri Lanka 4 2 50.0%
Thailand 5 0 0.0%
Subtotal (across 5/6 countries with CR; 83.3%) 47 32 68.1%
Western Pacific
Australia 314 85 27.1%
Brunei Darussalam 2 2 100.0%
China (including Macau) 218 83 38.1%
Japanb 325 9 2.8%
Malaysia 6 4 66.7%
Mongolia 1 1 100.0%
New Zealand 43 27 62.8%
Philippines 10 10 100.0%
Singapore 7 7 100.0%
South Korea 17 12 70.6%
Taiwan 35 23 65.7%
Subtotal (across 11/11 countries with CR; 100.0%) 978 263 26.9%
Total (across 93/111 countries; 83.7%) 3373 1082 32.1%
– = unknown; CR= cardiac rehabilitation; WHO=World Health Organization.
a Random sub-sample of 2632 programs (all CR programs were contacted in countries with ≤350 programs; otherwise, a random subsample of 250 were contacted).
b Sub-sample surveyed only, and therefore response rates actually higher (e.g., for Scotland the lead of each health region was surveyed, and there was a 100% response).
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should be explored.
4.2. CR Providers
Recommendations throughout the world are for multidisciplinary
involvement in the delivery of CR [21,27], without specific delineation
of types (some exceptions [19,23]), likely in recognition of differences
in availability of trained healthcare professionals, scope of practice,
and especially resources. While it was encouraging to find the average
program had six staff, the most efficient number in terms of optimizing
patient volumes warrants empirical consideration.
Globally, approximately 70% of programs were headed by some
form of physician, and the costs versus safety impacts of this shouldbe weighed empirically. For instance, models of care where physicians
are available for consultation based on pre-specified criteria versus all
patients having an individual consult with a physician may be more
cost-effective (as per 2/3rds of programs).
The limited availability of mental healthcare professionals, and even
pharmacists given the importance of optimal medical therapy, was
somewhat disconcerting. Nurses did appear to be offering these compo-
nents however, and overall played a key role in ensuring delivery of
most components. Given the effect of multidisciplinary team composi-
tion on clinical outcomes is not established empirically, it is perhaps
most important to ensure someone on staff has competence to deliver
each of the core components [19,22,38].
Staff-to-patient ratios varied statistically significantly by region
(higher in Europe), which may be due to variation in the number and
Fig. 1. Acute coronary syndrome, stable coronary artery disease, revascularization and heart failure as accepted indications⁎, by country. CR= cardiac rehabilitation. ⁎≥80% of responding
programs in country accept guideline-recommended indications of myocardial infarction/acute coronary syndrome, stable coronary artery disease, post-percutaneous coronary
intervention, coronary artery bypass graft surgery and heart failure patients.
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risk, among other factors [39]. Globally, programs in all regions gener-
ally have one staff member to four patients (and on average there
were 3 staff in each exercise session). Whether greater efficiency
could be achieved by serving more patients per session (while main-
taining safety), or through approaches to initiating new patients (who
need more attention; i.e., staggered/rolling start or group) should be
explored.
4.3. Core Components Delivered
Overall, delivery of the core componentswas high, but this varied re-
gionally and the quality of what was delivered in each component was
not assessed. However, some important elements of secondary preven-
tion recommendations for CVD [5] were not commonly offered in CR,
likely due to limited resources. Elements which are particularly impor-
tant in low-resource settings were also unfortunately infrequently of-
fered [26,27], namely tobacco cessation intervention/counseling
services and counseling for return-to-work.
4.4. Policy Implications
While overall results reflect high quality, a global CR program certi-
fication system may ensure more programs meet internationally-
agreed, evidence-based minimum standards [26,27]. The American
(http://www.aacvpr.org/Program-Certification) and British (http://
www.cardiacrehabilitation.org.uk/bacpr-nacr-certification.htm) CR so-
cieties have launched such programs in recent years. Perhaps the Inter-
national Council of Cardiovascular Prevention and Rehabilitation
(www.globalcardiacrehab.com) could work with these associations,
among others, to develop a certification program applicable to countries
around the world. A global certification program for CR providers of
multiple disciplines (including trainees) has recently been developed,
covering all core components (http://globalcardiacrehab.com/training-
opportunities/certification/) [26,27]. This may also promote improve-
ment in the quality of CR around the world.4.5. Limitations
Caution is necessary when interpreting the findings, particu-
larly due to limits on generalizability and potential bias. Firstly, re-
sponse rates to online surveys are notoriously low; in the current
study country response rate was very high, but program response
rates were moderate. Future replication will enable greater confi-
dence in the findings. Second, it may not have been possible to
identify all programs. Thirdly and on a related note, programs
would be more comprehensively identified in countries with soci-
eties and those affiliated with prominent academic centers
(i.e., ascertainment bias). Taken together, the quality of service at
responding centers may be higher than what is observed in an av-
erage CR program, and therefore results may reflect somewhat
higher-quality service provision than reality.
Fourth, respondentsmay have been inclined to respond in a socially-
desirable manner, such that results were skewed to reflect better qual-
ity CR provision. However, participants were informed that their re-
sponses were confidential. Fifth, responses were not verified in a
random sub-sample of programs, and hence the validity of self-report
is unknown. For example, programs may have reported screening for
depression, but utilized a non-psychometrically-validated tool. Finally,
the significance of the inferential tests reported herein should not be
interpreted to suggest significance from a health system, practice or
clinical perspective. Tests of regional differences should be considered
exploratory at this stage, with future research needed to further
investigate.5. Conclusion
CR programs were characterized globally for the first time, and
results suggested that where offered, quality is high. However,
gaps in the delivery of CR services were identified, as well as statis-
tically significant variation byWHO region. In particular, more con-
sistent delivery of tobacco cessation and return-to-work
Table 2
Healthcare professionals delivering cardiac rehabilitation, by regiona,b.
n (%) African
(n = 18)
Americas
(n = 261)
EMR
(n = 24)
European
(n = 484)
SEAR
(n = 32)
Western Pacific
(n = 263)
Total
(N = 1082)
pc
Personnel on CR team
Nurse 3
(21.4%)¶
175 (77.1%)
***
††
‖‖‖
20 (95.2%)
††
367 (94.1%)
***
22
(75.9%)
229 (93.5%)
‖‖‖
816
(88.1%)
b0.001
Dietitian 14 (87.5%) 171 (75.3%) 18 (85.7%) 305
(79.2%)
25 (89.3%) 206 (84.4%) 739
(80.2%)
0.82
Physiotherapist 11
(73.3%)
143 (63.3%) 14
(66.7%)
347 (89.0%) 23 (85.2%) 195 (79.6%) 733
(79.3%)
0.07
Cardiologist 9
(60.0%)
177 (77.6%) 18 (85.7%) 324 (83.1%) 28
(96.6%)
165 (67.9%) 721
(77.9%)
0.51
Administrative assistant/secretary 10 (71.4%) 157 (69.8%)
**
14 (70.0%) 289 (75.7%)
†††
‖
13 (46.4%)
‖
113 (47.3%)
**
†††
596
(65.6%)
0.001
Psychologist 6
(40.0%)
104 (46.2%)
*
7
(33.3%)
280 (72.4%)
*
†
17
(60.7%)
113
(47.9%)
†
527
(57.8%)
b0.05
Kinesiologist/exercise specialist 12
(75.0%)
134 (59.3%) 10 (47.6%) 201 (52.5%) 8
(28.6%)
112 (46.9%) 477
(52.2%)
0.36
Physiatrist/PM&R 5
(35.7%)
49 (22.6%) 13
(65.0%)
199 (52.5%) 10 (35.7%) 114 (47.3%) 389
(43.4%)
0.43
Social worker 2
(14.3%)
71
(32.6%)
8
(40.0%)
167 (4.0.2%) 6
(20.7%)
126 (52.1%) 380
(42.2%)
0.20
Pharmacist 1
(7.1%)
‖
55
(25.7%)
4
(20.0%)
119 (31.7%)
‖
8
(28.6%)
179 (74.0%) ¶¶¶ 366
(41.0%)
0.001
Psychiatrist 3
(21.4%)
31
(14.4%)
11
(55.0%)
95
(25.5%)
11
(40.7%)
57
(24.2%)
208
(23.5%)
0.10
Sports medicine physician 9
(56.3%)
37 (17.0%) 12 (57.1%) 71 (19.2%) 3
(10.7%)
51
(21.4%)
183
(20.5%)
0.21
Community health worker 1
(7.1%)
17 (7.9%) 3
(14.3%)
69
(18.5%)
3
(15.4%)
72
(30.3%)
166
(18.7%)
0.43
Other physician 3
(21.4%)
88 (41.3%) 10
(50.0%)
156 (42.2%) 17 (58.6%) 60
(26.3%)
334
(38.2%)
0.43
Other non-physicians 3
(30.0%)
43
(37.4%)
3
(27.3%)
65 (33.5%) 8
(57.1%)
49 (29.7%) 171
(33.6%)
0.66
Total # of program staff 4.7 ± 2.6 5.2 ± 2.2 6.4 ± 2.2 6.5 ± 3.1 5.5 ± 3.0 5.5 ± 2.7 5.9 ± 2.8 0.08
CR staff present during exercise
Physiotherapist 8
(80.0%)
120 (57.1%) 11 (68.8%) 261 (81.1%) 20 (83.3%) 157 (74.8%) 577
(72.9%)
0.29
Nurse 1
(10.0%)
138
(65.4%)
16 (94.1%) 223 (69.7%) 16 (66.7%) 181 (84.6%) 575
(72.2%)
0.08
Kinesiologist/exercise specialist 11 (78.6%) 116 (57.1%) 6
(40.0%)
123 (42.0%) 6
(26.1%)
59 (30.1%) 321
(43.1%)
0.06
Cardiologist 0
(0.0%)
57 (28.2%) 3
(20.0%)
98 (3.0.9%) 12 (48.0%) 76 (38.6%) 246
(32.6%)
0.64
Physiatrist/PM&R 1
(11.1%)
33 (17.1%) 6
(42.9%)
63 (21.9%) 3
(13.0%)
66 (33.7%) 172
(23.8%)
0.98
Dietitian 2
(22.2%)
24 (13.0%)
***
10 (66.7%)
***
‖‖‖
†††
◊◊
27 (10.1%)
‖‖‖
4
(17.4%)
◊◊
18
(9.3%)
†††
85
(12.3%)
0.001
Sports medicine physician 8
(57.1%)
15
(8.2%)
8
(47.1%)
27
(9.8%)
0
(0.0%)
21 (11.0%) 79
(11.2%)
0.29
Other physician 1
(11.1%)
25 (13.3%) 5
(38.5%)
25
(9.1%)
6
(24.0%)
16
(8.6%)
78
(11.2%)
0.08
Community health worker 0
(0.0%)
2
(1.1%)
1
(7.1%)
6
(2.3%)
0
(0.0%)
23 (12.2%) 32
(4.7%)
0.25
Other 2
(25.0%)
39 (29.3%) 1
(33.3%)
37 (18.5%) 2
(11.8%)
35 (23.8%) 116
(22.8%)
0.50
Total # of program staff present during exercise sessions
(mean ± SD)
2.6 ± 1.4 2.8 ± 1.4 4.5 ± 2.3 2.9 ± 1.8 3.1 ± 1.4 3.4 ± 2.1 3.1 ± 1.8 0.28
Number patients served per staff member (mean ± SD) 3.2 ± 1.7
*
4.4 ± 3.1 2.8 ± 1.3
†††
5.8 ± 12.1
*
†††
‖‖
3.1 ± 1.4 4.2 ± 3.4
‖‖
4.8 ± 8.0 b0.05
For pairwise comparisons *ǂ†◊‖¶: one symbol = p b .05; two symbols = p b .01; 3 symbols = p b .001.
¶Statistically significantly different from all regions.
CR = Cardiac Rehabilitation; EMR = Eastern Mediterranean Region; PM&R= Physical Medicine and Rehabilitation; SEAR = South-East Asia Region; SD= standard deviation.
Note: Due to missing data, percentages are computed where the denominator is the number of valid responses from responding programs.
a Data shown by country for most common healthcare professional types on CR team in Supplemental Table 3.
b Full-time personnel counted as 1 and part-time personnel counted as 0.50.
c Test for statistically significant differences by region, using generalized linear mixed models which accounted for clustering of programs within countries.
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Table 3
Cardiac rehabilitation components and other elements delivered, by region.
n (%) African (n
= 18)
Americas (n
=
261)
EMR (n =
24)
European (n
=
484)
SEAR (n
=
32)
Western Pacific
(n
= 263)
Total (N=
1082)
pb
Initial assessmenta 16
(100.0%)
236 (99.6%) 21
(100.0%)
394 (99.0%) 29
(100.0%)
243 (97.6%) 939
(98.8%)
0.99
Management of CV risk factorsa 15
(100.0%)
226 (96.2%) 21
(100.0%)
393 (98.5%) 29
(100.0%)
244 (99.2%) 928
(98.2%)
0.92
Patient educationa 15
(100.0%)
223 (97.8%) 21
(100.0%)
374 (97.1%) 26
(96.3%)
236 (95.2%) 895
(96.9%)
1.0
Exercise traininga 16
(100.0%)
*
††
ǂǂǂ
230 (97.0%)
*
‡
19
(90.5%)
390 (97.3%)
††
◊
28
(96.6%)
215 (86.7%)
ǂǂǂ
◊
‡
898
(94.3%)
b0.05
Heart rate measurement training/exercise intensity monitoring 15
(93.8%)
235 (99.6%) 20
(95.2%)
379 (95.7%) 29
(100.0%)
210 (85.4%) 888
(94.1%)
0.34
Risk assessmenta 15
(93.8%)
220 (96.1%) 18
(100.0%)
318 (94.4%) 23
(92.0%)
194 (89.0%) 788
(93.5%)
0.78
Assessment of Comorbidities 15
(100.0%)
218 (92.8%) 19
(90.5%)
378 (95.7%) 25
(92.6%)
222 (89.2%) 877
(93.1%)
0.60
Nutrition counselinga 12
(75.0%)
211 (89.0%) 20
(95.2%)
376 (94.5%) 28
(96.6%)
233 (94.0%) 880
(92.7%)
0.58
End of program re-assessmenta 16
(100.0%)
217 (93.1%) 19
(90.5%)
364 (91.9%) 23
(82.1%)
219 (89.4%) 858
(91.4%)
0.82
Resistance training 15
(93.8%)
220 (94.0%) 15
(71.4%)
363 (91.2%) 28
(96.6%)
217 (87.9%) 858
(90.8%)
0.23
Depression screening 11
(73.3%)
193 (81.8%) 19
(90.5%)
367 (92.2%) 20
(69.0%)
206 (83.4%) 816
(86.3%)
0.11
Communication of assessment results to patients' primary care
providera
16
(100.0%)
191 (80.9%) 15
(71.4%)
333 (85.4%) 22
(78.6%)
211 (85.4%) 788
(84.0%)
0.69
Stress managementa 10
(66.7%)
184 (78.3%) 17
(81.0%)
341 (85.9%) 22
(75.9%)
197 (79.8%) 771
(81.7%)
0.52
Psychological counseling 9
(60.0%)
166 (70.6%) 18 (85.7%) 343 (86.2%) 22
(75.9%)
194 (78.2%) 752
(79.5%)
0.12
Prescription and/or titration of medications 12
(75.0%)
167 (70.8%) 20
(95.2%)
352 (88.4%) 27
(93.1%)
173 (70.0%) 751
(79.3%)
0.10
Other functional capacity test 14
(93.3%)
182 (78.4%) 14
(70.0%)
330 (84.6%) 25
(89.3%)
169 (69.0%) 734
(78.9%)
0.26
Smoking cessation sessions/classesa 8
(53.3%)
138 (58.5%)
***
†
‡‡‡
ǂǂǂ
15
(75.0%)
†
318 (79.9%)
***
25
(86.2%)
ǂǂǂ
188 (76.4%)
‡‡‡
692
(73.3%)
0.001
Follow-up post-program 14
(87.5%)
156 (66.4%) 14
(70.0%)
256 (65.0%) 23
(79.3%)
199 (80.9%) 662
(70.4%)
0.07
Exercise stress test 13
(81.3%)
144 (62.3%) 18
(90.0%)
310 (78.5%) 25
(86.2%)
146 (59.3%) 656
(70.0%)
0.71
Vocational counseling/return-to-worka 7
(46.7%)
107 (46.1%)
***
ǂǂ
15
(71.4%)
296 (75.1%)
***
18
(64.3%)
171 (70.1%)
ǂǂ
614
(65.7%)
0.001
Electronic patient charting 11
(78.6%)
144 (68.2%) 12
(57.1%)
166 (63.4%) 11
(40.7%)
128 (54.0%) 472
(61.1%)
0.48
Assessment of strength 12
(80.0%)
88 (38.3%) 11
(52.4%)
183 (46.7%) 15
(51.7%)
138 (57.3%) 447
(48.2%)
0.21
Alternative forms of exercise (e.g., yoga, dance) 6
(40.0%)
81 (34.8%) 6
(30.0%)
136 (34.7%) 16
(57.1%)
110 (44.9%) 355
(38.0%)
0.65
Women-only classes 3
(20.0%)
19
(8.2%)
**
11
(52.4%)
**
ǂ
††
‡
45
(11.6%)
ǂ
3
(10.7%)
‡
29
(11.8%)
††
110
(11.8%)
b0.01
Other 2
(66.7)
26 (27.4%) 1
(14.3%)
30 (18.2%) 6 (40.0%) 48 (36.9%) 113
(27.2%)
0.09
Total elements (mean ± SD) 19.6 ± 3.0 19.1 ± 3.7 20.0 ± 3.4 20.2 ± 3.7 19.3 ±
3.9
18.5 ± 5.0 19.5 ± 4.1 0.38
Total core (/11)a 8.4 ± 1.4 8.6 ± 1.7 8.9 ± 1.7 9.0 ± 1.8 8.6 ± 1.7 8.4 ± 2.1 8.7 ± 1.9 0.77
EMR = Eastern Mediterranean Region; SEAR = South-East Asia Region; SD = standard deviation.
For pairwise comparisons *ǂ‡†◊: one symbol = p b .05; two symbols = p b .01; 3 symbols = p b .001.
a Quality indicator/core component.
b Test for significant differences by region, using generalized linear mixed models which accounted for clustering of programs within countries.
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leadership, staff-to-patient ratios and acceptance of non-cardiac
patients require further investigation. Resources, policy changes,and certification systems are needed to ensure all programs meet
minimum standards for CR delivery [26,27] which ensure optimal
patient safety and outcomes.
Table 4
Cardiac rehabilitation quality indicators, by region.
Mean ± SD or n (%) African
(n = 18)
Americas
(n = 261)
EMR
(n = 24)
European
(n = 484)
SEAR
(n = 32)
Western Pacific
(n = 263)
Total
(N = 1082)
pd
Time to enrolment (weeks)b 6.8 ± 4.0 4.2 ± 4.3 5.2 ± 5.8 3.6 ± 3.7 2.4 ± 1.4 2.6 ± 1.9 3.5 ± 3.6 0.11
Component quality
Initial assessment 16
(100.0%)
236
(99.6%)
21
(100.0%)
394
(99.0%)
29 (100.0%) 243
(97.6%)
939
(98.8%)
0.98
Management of CV risk factors 15
(100.0%)
226
(96.2%)
21
(100.0%)
393
(98.5%)
29
(100.0%)
244 (99.2%) 928
(98.2%)
0.92
Patient education 15 (100.0%) 223 (97.8%) 21 (100.0%) 374 (97.1%) 26 (96.3%) 236 (95.2%) 895 (96.9%) 1.0
Exercise counseling/prescription and/or training 16 (100.0%)
ø
††
ǂǂǂ
230 (97.0%)
ø
‡
19
(90.5%)
390 (97.3%)
††
◊
28 (96.6%) 215 (86.7%)
ǂǂǂ
◊
‡
898 (94.3%) b0.05
Risk assessment 15 (93.8%) 220 (96.1%) 18 (100.0%) 318 (94.4%) 23 (92.0%) 194 (89.0%) 788 (93.5%) 0.99
Nutrition counseling 12
(75.0%)
211 (89.0%) 20
(95.2%)
376
(94.5%)
28
(96.6%)
233
(94.0%)
880
(92.7%)
0.58
End of program re-assessment 16
(100.0%)
217
(93.1%)
19 (90.5%) 364
(91.9%)
23
(82.1%)
219
(89.4%)
858
(91.4%)
0.82
Communication with a primary care provider 16 (100.0%) 191 (80.9%) 15
(71.4%)
333 (85.4%) 22 (78.6%) 211 (85.4%) 788 (84.0%) 0.69
Stress management 10
(66.7%)
184
(78.3%)
17
(81.0%)
341
(85.9%)
22
(75.9%)
197
(79.8%)
771
(81.7%)
0.52
Tobacco cessation interventions 8
(53.3%)
138 (58.5%)
øøø
†
‡‡‡
ǂǂǂ
15
(75.0%)
†
318 (79.9%)
øøø
25 (86.2%)
ǂǂǂ
188 (76.4%)
‡‡‡
692 (73.3%) 0.001
Vocational counseling/support for return to work 7
(46.7%)
107 (46.1%)
***
ǂǂ
15
(71.4%)
296 (75.1%)
***
18 (64.3%) 171 (70.1%)
ǂǂ
614 (65.7%) 0.001
Risk factor assessment quality
Blood pressure 16
(100.0%)
234 (99.6%) 21 (100.0%) 385 (98.7%) 29 (100.0%) 243 (99.2%) 928
(99.1%)
0.99
Tobacco use 16 (100.0%) 231
(98.3%)
21 (100.0%) 382
(97.4%)
28
(96.6%)
241
(98.4%)
919
(98.0%)
0.99
Adipositya 16 (100.0%) 226 (96.2%) 21 (100.0%) 378 (96.2%) 29 (100.0%) 220 (93.6%) 900
(95.8%)
0.88
Physical inactivity 16 (100.0%) 220 (94.0%) 20
(95.2%)
371 (95.6%) 24
(82.8%)
228 (93.4%) 879 (94.3%) 0.28
Lipids 12
(75.0%)
218 (92.8%) 21 (100.0%) 365 (93.1%) 28
(96.6%)
212 (86.5%) 853 (91.03%) 0.46
Poor diet 14 (87.5%) 217 (92.7%) 20 (95.2%) 358 (91.8%) 21 (75.0%) 210 (86.4%) 840 (90.1%) 0.23
Glucose/HbA1c 14
(87.5%)
212
(90.2%)
21 (100.0%) 347
(89.0%)
26
(96.3%)
202
(83.5%)
827
(88.4%)
0.99
Depression 13
(81.3%)
192
(83.1%)
18
(85.7%)
352
(90.5%)
19
(65.5%)
203
(83.5%)
797
(85.8%)
0.60
# Quality/20c 16.0 17.0 17.0 20.0 18.0 19.0 18.0 0.77
Quality rank 5 4 4 1 3 2 3
For pairwise comparisons •‡ø£†¥∂◊: one symbol = p b .05; two symbols = p b .01; 3 symbols = p b .001.
CR = Cardiac Rehabilitation; EMR = Eastern Mediterranean Region; SEAR = South-East Asia Region; SD= standard deviation.
Note:Overall quality by country shown in Supplemental Table 9. Due tomissing data, percentages are computedwhere the denominator is the number of valid responses from responding
programs.
a Waist or hip circumference or body mass index.
b Benchmark is 4 weeks.
c Number ≥ 75% (or b 4 weeks for wait time).
d Test for statistically significant differences by region, using generalized linear mixed models which accounted for clustering of programs within countries.
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More needs to be known about the impact of each quality indicator
on patient safety and outcomes, in diverse contexts, such that efforts can
be directed to ensure key indicators are met universally. Indeed, while
the survey assessed structure and process indicators of programs, how
these translate to patient outcomes cannot be ascertained. Field tests
of CR programs, examining the how and what is delivered in each
core component, and degree of control of identified risk factors achieved
is warranted, thus also validating survey items. For countries with a na-
tional registry [40], and it would be ideal to link this structural program
data to the patient-level data in the registry to determine the degree of
quality of CR. Moreover, CR delivery could then be benchmarked across
these countries.Supplementary data to this article can be found online at https://doi.
org/10.1016/j.eclinm.2019.06.006.
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